These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
489 related items for PubMed ID: 25482947
1. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels. Goudarzi KM, Nistér M, Lindström MS. Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947 [Abstract] [Full Text] [Related]
2. Nucleolar Stress Response via Ribosomal Protein L11 Regulates Topoisomerase Inhibitor Sensitivity of P53-Intact Cancers. Ishihara Y, Nakamura K, Nakagawa S, Okamoto Y, Yamamoto M, Furukawa T, Kawahara K. Int J Mol Sci; 2022 Dec 15; 23(24):. PubMed ID: 36555627 [Abstract] [Full Text] [Related]
7. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Bursać S, Brdovčak MC, Pfannkuchen M, Orsolić I, Golomb L, Zhu Y, Katz C, Daftuar L, Grabušić K, Vukelić I, Filić V, Oren M, Prives C, Volarevic S. Proc Natl Acad Sci U S A; 2012 Dec 11; 109(50):20467-72. PubMed ID: 23169665 [Abstract] [Full Text] [Related]
8. Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner. Mahata B, Sundqvist A, Xirodimas DP. Oncogene; 2012 Jun 21; 31(25):3060-71. PubMed ID: 22081073 [Abstract] [Full Text] [Related]
12. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status. Nagata Y, Takahashi A, Ohnishi K, Ota I, Ohnishi T, Tojo T, Taniguchi S. Int J Oncol; 2010 Oct 21; 37(4):1001-10. PubMed ID: 20811722 [Abstract] [Full Text] [Related]
15. The activation of the p53 pathway by the AMP mimetic AICAR is reduced by inhibitors of the ATM or mTOR kinases. Zajkowicz A, Rusin M. Mech Ageing Dev; 2011 Oct 21; 132(11-12):543-51. PubMed ID: 21945951 [Abstract] [Full Text] [Related]
17. The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells. Dong Z, Zhu C, Zhan Q, Jiang W. Oncotarget; 2017 Feb 21; 8(8):13240-13252. PubMed ID: 28099941 [Abstract] [Full Text] [Related]
18. Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells. Daniele S, Costa B, Zappelli E, Da Pozzo E, Sestito S, Nesi G, Campiglia P, Marinelli L, Novellino E, Rapposelli S, Martini C. Sci Rep; 2015 Apr 21; 5():9956. PubMed ID: 25898313 [Abstract] [Full Text] [Related]
19. HEY1 functions are regulated by its phosphorylation at Ser-68. López-Mateo I, Arruabarrena-Aristorena A, Artaza-Irigaray C, López JA, Calvo E, Belandia B. Biosci Rep; 2016 Jul 21; 36(3):. PubMed ID: 27129302 [Abstract] [Full Text] [Related]
20. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Sasaki M, Kawahara K, Nishio M, Mimori K, Kogo R, Hamada K, Itoh B, Wang J, Komatsu Y, Yang YR, Hikasa H, Horie Y, Yamashita T, Kamijo T, Zhang Y, Zhu Y, Prives C, Nakano T, Mak TW, Sasaki T, Maehama T, Mori M, Suzuki A. Nat Med; 2011 Jul 31; 17(8):944-51. PubMed ID: 21804542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]